science wire

« BACK

Pharmacology



Results 201 - 250 of 1819.


Pharmacology - Health - 17.02.2020
Talking back pain with U of M
Back pain is the leading cause of disability worldwide and an estimated 80% of the population will experience back pain at some time in their lives, according to the American Chiropractic Association.

Pharmacology - Health - 13.02.2020
Instant prescriptions: we need to manage the risks
Instant prescriptions: we need to manage the risks
Instant prescriptions might be the way of our digital future, but we need to manage the risks first, write academics from our Faculty of Medicine and Health.

Pharmacology - Health - 11.02.2020
GPs and pharmacists need to develop trusting relationships
The research, published in the British Journal of General Practice today [11 February], asked GPs and pharmacists about their views on what helps and what hinders them from working together to make the best use of medicines for patients with multiple health problems. The study found that 'knowing each other' and a good working relationship were key to working together well.

Pharmacology - Health - 11.02.2020
Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
Patients & Caregivers Healthcare Professionals Society & ESG FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping

Health - Pharmacology - 11.02.2020
Talking cancer prevention with U of M
February is National Cancer Prevention Month. In Minnesota, there are an estimated 142,369 new cancer cases every year.  Professor Timothy Church with the University of Minnesota answers questions on lifestyle changes people can make to reduce their risk of getting cancer.

Health - Pharmacology - 05.02.2020
Countering therapy resistance in colorectal cancer - News
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL. Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality.

Health - Pharmacology - 02.02.2020
Singing for joy and service
Singing for joy and service
After surgery to correct childhood hearing loss, Swarna Jeewajee discovered a a desire to be a physician-scientist, and a love of a cappella music.

Health - Pharmacology - 30.01.2020
Heart surgeon dedicates career to helping patients no one else can save
Nearly three decades ago, Valluvan Jeevanandam was six months into his first job as a heart surgeon when a critically ill patient pleaded with him: Get me a transplant today, or I am going to die.

Pharmacology - Health - 30.01.2020
Mothers on antiepileptic medication can safely breastfeed
Breastfeeding is associated with benefits for children and their mothers. However, when mothers take medications there is a potential for adverse side effects in the infant.

Health - Pharmacology - 30.01.2020
U.S. rural breast cancer patients must routinely travel long distances for treatment
The closing of rural hospitals and specialty care units is causing many people, including breast cancer patients, to seek treatment far from home.

Pharmacology - Health - 29.01.2020
& Development for Parasitic Worm Infections Lags Behind
& Development for Parasitic Worm Infections Lags Behind
Neglected tropical diseases (NTDs) are a group of mainly chronic infectious diseases that affect more than a billion people in tropical and subtropical countries.

Health - Pharmacology - 28.01.2020
The universities of Bern and Zurich offer continuing education in gender-specific medicine
The universities of Bern and Zurich offer continuing education in gender-specific medicine
There is increasing evidence that health behavior and disease manifestation differ substantially between women and men.

Pedagogy - Pharmacology - 28.01.2020
The Daily Mile(TM) programme can be part of schools’ work on childhood obesity prevention
A study evaluating the effectiveness of the widely used ‘Daily Mile' intervention in schools to tackle childhood obesity has found that the benefits are small, and may be greater in girls than boys.

Life Sciences - Pharmacology - 28.01.2020
More than a knee injury: ACL tears cause harmful changes in our brain structure
More than a knee injury: ACL tears cause harmful changes in our brain structure
It's known that some joint function is often permanently lost after anterior cruciate ligament reconstruction, and re-injury is common even with intensive physical therapy, but it's unclear why. New research from the University of Michigan School of Kinesiology shows structural changes in the brains of patients who underwent ACL reconstruction.

Health - Pharmacology - 27.01.2020
Six patients with rare blood disease are doing well after gene therapy clinical trial
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD.

Pharmacology - Health - 27.01.2020
Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer
Application is being reviewed under FDA's Real-Time Oncology Review pilot programme Roche today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Fo

Pharmacology - Life Sciences - 24.01.2020

Pharmacology - Life Sciences - 24.01.2020
UQ responds to coronavirus outbreak
The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.

Pharmacology - Life Sciences - 23.01.2020
’A Tornado at the Front Door, a Tsunami at the Back Door’
20-year-old born with rare disease arrives at crossroads: continue toward future most likely leading to early death or become first patient to undergo new gene-and-stem cell therapy developed by Scho

Health - Pharmacology - 23.01.2020
Q&A: Coronavirus outbreak and health policy implications
The outbreak of a novel coronavirus that began in December 2019 in Wuhan, China "is evolving and complex," said the head of the World Health Organization (WHO) after its emergency committee convened

Pharmacology - Health - 23.01.2020

Pharmacology - Innovation - 22.01.2020
Launch of Bristol: Take Drugs Seriously
A series of ground-breaking events that aim to change the way we talk about drug use, policy and harm reduction launches in Bristol tomorrow [Thursday 23 January].

Pharmacology - 22.01.2020

Health - Pharmacology - 22.01.2020
Antiviral treatments inspire new kind of cancer drug
Antiviral treatments inspire new kind of cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold - but the lessons they've learned fighting viruses has led to a new kind of drug that has been effective at treating cancer in mice.

Pharmacology - Health - 21.01.2020
American dreams come true for Fulbright scholars
American dreams come true for Fulbright scholars
University of Queensland scientists are heading ‘stateside' with the support of 2020 Fulbright scholarships.

Pharmacology - Health - 21.01.2020
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma
Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b Targeted off-the-shelf treatment provides much-needed new option for people with relapsed or

Pharmacology - Health - 20.01.2020
Novartis announces EU approval of Mayzent (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
Patients & Caregivers Healthcare Professionals Society & ESG Mayzent (siponimod) is the first and only oral treatment specifically indicated for patients with secondary progressive multiple s

Pharmacology - Health - 15.01.2020
We must be smarter about how we use antibiotics, says Imperial researcher
Not enough focus is being paid to using antibiotics more appropriately to minimise the threat of drug-resistant bugs, said an expert in a recent talk. Alison Holmes, Professor of Infectious Diseases at Imperial College London and Director of Infection Prevention and Control at Imperial College Healthcare NHS Trust, is leading a newly created centre to tackle drug-resistant infections.

Pharmacology - Health - 15.01.2020
Involving family in care for bipolar disorder helps children and teens stay healthier, longer
In a UCLA-led study, children and adolescents with a high risk for developing bipolar disorder stayed healthier for longer periods when their family members participated in their psychotherapy sessions.

Health - Pharmacology - 15.01.2020
Drug resistance is "up there with climate change" as a global threat
The threat posed by drug resistant infections should be taken as seriously as climate change, says an Imperial expert.

Health - Pharmacology - 15.01.2020
Genome editing at the crossroads of scandal and cure
Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics.

Health - Pharmacology - 14.01.2020
New heart disease drug to be made available to NHS patients through ground-breaking collaboration
Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease - a leading cause of death in the UK.

Pharmacology - Health - 13.01.2020
Project aims to improve diagnosis and treatment for patients with anaemia
Ambulatory care specialists at the University of Birmingham, with support from Vifor Pharma UK Limited (VPUK), are working to develop and implement a population based anaemia diagnosis and treatment decision support service for routine healthcare delivery.

Pharmacology - Health - 10.01.2020
New partnership with international pharmaceutical company provides up to $10 million for drug development research at U-M
New partnership with international pharmaceutical company provides up to $10 million for drug development research at U-M
The University of Michigan and Sun Pharma Advanced Research Company have launched a partnership to accelerate the development of potential new medicines for a wide range of diseases. The new venture will provide up to a total of $10 million in financial support and in-kind industry resources to move various promising drug-discovery research projects within the university toward the ultimate goal of new therapies for patients.

Health - Pharmacology - 10.01.2020
Cancer researchers call for ambitious survival targets for the 2020s
The NHS should raise their five-year lung cancer survival targets to 35% by 2030, concludes a new 'state of the nation' policy report conducted by UCL.

Health - Pharmacology - 09.01.2020
First patient for Parkinson's disease trial recruited
First patient for Parkinson’s disease trial recruited
The trial, funded by a £2.1 million grant from the National Institute for Health Research (NIHR) , will test whether a commonly prescribed dementia drug could prevent debilitating falls for people with the disease.

This site uses cookies and analysis tools to improve the usability of the site. More information. |